Evident and incredible ideas about mutation process in humans
Bochkov, N.P.; Durnev, A.D.
Gigiena i Sanitariia 5: 9-10
2011
ISSN/ISBN: 0016-9900 PMID: 22184991 Document Number: 649339
The paper briefly formulates the main regularities of a human mutation process and defines the major topical lines of investigations in this area. It shows it necessary to take into account the known regularities of a mutation process when forming the legislative and legal bases for assuring the genetic safety of environmental factors.
Document emailed within 1 workday
Related Documents
Khaitov, R.M.; Alekseev, L.P.; Boldyreva, M.N. 2006: New ideas of the physiological role of the genes' HLA in reproductive process Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 92(4): 393-401Berg, R.L.; Kryshova, N.A.; Ozeretskovskaia, N.G.; Artemchuk, N.L.; Begzhanov, K.B. 1973: Population-genetic approach to studying the mutation process using 4 forms of myopathy as an example Genetika 9(10): 127-138
Wiinblad, L.; Hjorth, P.S. 1992: Analysis of a judgment investigation. Incredible Sygeplejersken 92(16-17): 14-17
1995: Labeling has caused "incredible confusion" Contraceptive Technology Update 16(4): 49-51
Tikhomirova, M.M. 1980: Relationship between the body's adaptation to heat and the modifying effect of extreme temperature on the effect of radiation. III. Role of genotype and environment in determining the intensity of the mutation process Genetika 16(3): 470-477
Keil, G.; Paré, A. 1990: So-called initial description of phantom pain by Ambroise Paré. "Chose digne d'admiration et quasi incredible": the "douleur ès parties mortes et amputées" Fortschritte der Medizin 108(4): 62-66
Nolgård, K. 1987: Art library in the hospital: "culture a self-evident right" Vardfacket 11(4): 6-7
Fedorenko, A.E.; Slobodianik, G.I. 1998: Experience in identifying some non-self-evident correlations in syphilis Likars'ka Sprava 8: 146-149
Happich, D.; Madlener, K.; Schwaab, R.; Hanfland, P.; Pötzsch, B. 2000: Application of the TaqMan-PCR for genotyping of the prothrombin G20210A mutation and of the thermolabile methylenetetrahydrofolate reductase mutation Thrombosis and Haemostasis 84(1): 144-145
Zilfalil, B.A.; Sarina, S.; Liza-Sharmini, A.T.; Oldfield, N.J.; Stenhouse, S.A. 2006: Detection of F508del mutation in cystic fibrosis transmembrane conductance regulator gene mutation among Malays Singapore Medical Journal 47(2): 129-133
Sandritter, W. 1978: The self evident aspect of pathology. Chairman's opening address Verhandlungen der Deutschen Gesellschaft für Pathologie 62: Xxxi-Xxxvi
Naumov, L.S.; Savchenko, G.V.; Prozorov, A.A. 1974: Mapping of the Bacillus subtilis chromosome region carrying the rec 342 mutation (mutation decreasing the activity of ATP-dependent deoxyribonuclease) Genetika 10(2): 126-131
Kawamura, J.; Kato, S.; Ishihara, T.; Hiraishi, Y.; Kawashiro, T. 1997: Difference of new mutation rates in dystrophin gene between deletion and duplication mutation in Duchenne and Becker muscular dystrophy Rinsho Shinkeigaku 37(3): 212-217
Riggins, W.S. 2005: Tackling disaster: medicine's "trusted agent" role becomes evident Texas Medicine 101(11): 7-8
Terlizzi, R.; Canel, F.; Desideri, A.; Suzzi, G.; Celegon, L. 1999: What is evident is not always true. Epistemological reflections on evidence-based medicine Giornale Italiano di Cardiologia 29(9): 1041-1043
Raya Sánchez, J.M. 2003: Iron deficiency without evident haemorrhagic losses: a challenge for the clinical practice? Anales de Medicina Interna 20(5): 225-226
Wang, L.S.; Chen, G.Q.; Wang, X.E. 1995: Contrast study on the cases of peptic ulcer evident bleeding induced causes Zhonghua Liu Xing Bing Xue Za Zhi 16(3): 164-165
Meyer, W.; Pakur, M. 1999: Thoughts about the domestic dog as the catalyst for relations between humans and a body contact object for humans Schweizer Archiv für Tierheilkunde 141(8): 351-359
Hedley, A.J. 1997: The tobacco industry and scientific publications. Challenges on grounds of self evident potential bias are not unfair Bmj 314(7090): 1350
Lethagen, S.; Isaksson, C.; Schaedel, C.; Holmberg, L. 2002: Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X) Thrombosis and Haemostasis 88(3): 421-426